Literature DB >> 20197200

Polymorphisms of the gamma-glutamyl hydrolase gene and risk of relapse to acute lymphoblastic leukemia in Mexico.

Jorge Organista-Nava1, Yazmín Gómez-Gómez, Mónica Virginia Saavedra-Herrera, Ana Bertha Rivera-Ramírez, Marco Antonio Terán-Porcayo, Luz Del Carmen Alarcón-Romero, Berenice Illades-Aguiar, Marco Antonio Leyva-Vázquez.   

Abstract

This study evaluated the association of -401C/T and +452C/T polymorphisms of gamma-glutamyl hydrolase and the risk of relapse to acute lymphoblastic leukemia. Genotyping was performed in 70 children with acute lymphoblastic leukemia and 140 healthy children. An association between the -401C/T polymorphism and the risk of relapse was found (p=0.028), patients with the -401T/T genotype have 10.83 (95% CI 1.30-90.14) more chance of a relapse of leukemia. No association was found between the +452C/T polymorphism and the risk of relapse. Therefore, our investigation suggests that the -401C/T polymorphism in the gamma-glutamyl hydrolase may be a factor involved in the generation of relapse to disease in patients with ALL. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20197200     DOI: 10.1016/j.leukres.2009.11.027

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  6 in total

Review 1.  Gene polymorphisms in the folate metabolism and their association with MTX-related adverse events in the treatment of ALL.

Authors:  Yang Chen; Zuojun Shen
Journal:  Tumour Biol       Date:  2015-05-30

2.  γ-Glutamyl hydrolase modulation significantly influences global and gene-specific DNA methylation and gene expression in human colon and breast cancer cells.

Authors:  Sung-Eun Kim; Toshinori Hinoue; Michael S Kim; Kyoung-Jin Sohn; Robert C Cho; Peter D Cole; Daniel J Weisenberger; Peter W Laird; Young-In Kim
Journal:  Genes Nutr       Date:  2014-12-13       Impact factor: 5.523

3.  Comparative pharmacogenetic analysis of risk polymorphisms in Caucasian and Vietnamese children with acute lymphoblastic leukemia: prediction of therapeutic outcome?

Authors:  Phuong Thu Vu Hoang; Jérôme Ambroise; Anne-France Dekairelle; Jean-François Durant; Valentina Butoescu; Vu Luan Dang Chi; Nghia Huynh; Tan Binh Nguyen; Annie Robert; Christiane Vermylen; Jean-Luc Gala
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

4.  Survival and risk of relapse of acute lymphoblastic leukemia in a Mexican population is affected by dihydrofolate reductase gene polymorphisms.

Authors:  Yazmín Gómez-Gómez; Jorge Organista-Nava; Mónica Virginia Saavedra-Herrera; Ana Bertha Rivera-Ramírez; Marco Antonio Terán-Porcayo; Luz Del Carmen Alarcón-Romero; Berenice Illades-Aguiar; Marco Antonio Leyva-Vázquez
Journal:  Exp Ther Med       Date:  2012-01-09       Impact factor: 2.447

5.  High miR-24 expression is associated with risk of relapse and poor survival in acute leukemia.

Authors:  Jorge Organista-Nava; Yazmín Gómez-Gómez; Berenice Illades-Aguiar; Luz Del Carmen Alarcón-Romero; Mónica Virginia Saavedra-Herrera; Ana Bertha Rivera-Ramírez; Víctor Hugo Garzón-Barrientos; Marco Antonio Leyva-Vázquez
Journal:  Oncol Rep       Date:  2015-02-06       Impact factor: 3.906

6.  Effect of folylpolyglutamate synthase A22G polymorphism on the risk and survival of patients with acute lymphoblastic leukemia.

Authors:  Yazmín Gómez-Gómez; Jorge Organista-Nava; Carlos Alberto Rangel-Rodriguez; Berenice Illades-Aguiar; María Elena Moreno-Godínez; Luz Del Carmen Alarcón-Romero; Marco Antonio Leyva-Vázquez
Journal:  Oncol Lett       Date:  2014-05-26       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.